Pfizer Inc. is building on the experience gained during the pandemic, and the unprecedented windfall of profits from its COVID-19 vaccine, to roll out a plan it calls “An Accord for a Healthier World” that will provide current and future patented medications and vaccines on a not-for-profit basis to 45 lower-income countries, beginning with Rwanda, Ghana, Malawi, Uganda and Senegal. CEO Albert Bourla told the World Economic Forum in Davos, Switzerland, on 25 May the initiative will build on what has been learned in providing COVID-19 vaccines globally and address the many obstacles to health care equity in less wealthy nations.
The effort is expected to benefit 1.2 billion people in the 45 lower-income or lower-middle-income countries, most in the southern...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?